• Benign Prostatic Hyperplasia
  • Hormone Therapy
  • Genomic Testing
  • Next-Generation Imaging
  • UTUC
  • OAB and Incontinence
  • Genitourinary Cancers
  • Kidney Cancer
  • Men's Health
  • Pediatrics
  • Female Urology
  • Sexual Dysfunction
  • Kidney Stones
  • Urologic Surgery
  • Bladder Cancer
  • Benign Conditions
  • Prostate Cancer

UPCOMING SERIES: Deep Data Dive: Highlights From ASCO 2024 on the Treatment of High-Risk BCG-Unresponsive NMIBC

Opinion
Video

Trinity Bivalacqua, MD, PhD, announces an upcoming UroView series highlighting key information presented at ASCO 2024 surrounding treatment of high-risk BCG-unresponsive NMIBC.

Related Videos
Video 2 - "Exploring Treatments for BCG-Unresponsive Intermediate-High Risk NMIBC"
Video 1 "Unmet Needs & Standard of Care for Intermediate-High Risk NMIBC"
Video 4 - "The Role of a Multidisciplinary Team in Managing Kidney Cancer"
Video 2 - "Diagnostic Tests for Kidney Cancer"
Video 1 - "A Growing Incidence of Renal Masses"
Video 7 - "Multidisciplinary Collaboration and Expert Insights in the Management of Advanced Prostate Cancer"
Video 6 - "Emerging AR Targeting Agents and CDK4/6 Inhibitors in Metastatic Prostate Cancer and Potential Impact on the Treatment Landscape"
Video 5 - "Targeting the Androgen Receptor Pathway and Overcoming Treatment Resistance in Advanced Prostate Cancer"
Related Content
doctor holding a pen talking to patient

Study finds only half of patients undergoing 24-hour urine tests receive complete testing

Hannah Clarke
December 14th 2022
Article

“One of the goals of this study was to look at whether 24-hour urine testing in the VA population included all the important components of 24-hour urine panel testing,” says Ryan Hsi, MD, FACS.

Dr. Chew and Dr. Bhojani highlight their findings on sepsis rates post ureteroscopy

Dr. Chew and Dr. Bhojani highlight their findings on sepsis rates post ureteroscopy

Urology Times staff
November 2nd 2022
Article

Naeem Bhojani, MD, and Ben H. Chew, MD, MSc, FRCSC, discuss the burden of sepsis post-URS to both the healthcare system and patients.

Doctor discusses treatment information with patient

Study finds inadequate patient education for scheduled urologic procedures

Hannah Clarke
October 19th 2022
Article

Researchers at Albert Einstein College of Medicine found patients benefited from a pre-procedural interview to educate them about the risks, benefits, and alternatives to urologic treatments they were scheduled to receive.

First European patient treated for urethral stricture with novel drug-coated balloon catheter

First European patient treated for urethral stricture with novel drug-coated balloon catheter

Jason M. Broderick
February 2nd 2021
Article

The Optilume drug-coated balloon catheter system was approved in the EU in September 2020 for the treatment of patients with urethral stricture.

FDA approves lumasiran as first drug for primary hyperoxaluria type 1

FDA approves lumasiran as first drug for primary hyperoxaluria type 1

Jason M. Broderick
November 24th 2020
Article

The treatment is approved for both adult and pediatric patients.

© 2024 MJH Life Sciences

All rights reserved.